The global anticoagulants market is poised for robust growth, projected to surge from USD 41.31 billion in 2024 to USD 89.50 billion by 2033, expanding at a CAGR of 8.97% during the forecast period (2025–2033). This growth is propelled by a sharp rise in cardiovascular disease (CVD) incidence, technological advancements, and a shift toward novel oral anticoagulants (NOACs). Want pricing...